- Report
- October 2023
- 172 Pages
Global
From €4059EUR$4,500USD£3,480GBP
- Drug Pipelines
- July 2025
- 60 Pages
Global
From €1127EUR$1,250USD£967GBP
- Clinical Trials
- April 2025
- 120 Pages
Global
From €1804EUR$2,000USD£1,547GBP
- Report
- December 2024
- 119 Pages
Global
From €3563EUR$3,950USD£3,055GBP
- Report
- March 2024
- 238 Pages
Global
From €7170EUR$7,950USD£6,148GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4464EUR$4,950USD£3,828GBP
- Drug Pipelines
- February 2022
- 74 Pages
Global
From €3563EUR$3,950USD£3,055GBP
- Clinical Trials
- July 2025
- 60 Pages
Global
From €1353EUR$1,500USD£1,160GBP
- Report
- June 2025
- 200 Pages
Global
From €2515EUR$2,789USD£2,157GBP
- Report
- May 2025
- 231 Pages
Global
From €2255EUR$2,500USD£1,933GBP
- Report
- November 2021
- 120 Pages
Global
From €2255EUR$2,500USD£1,933GBP
- Report
- May 2024
- 136 Pages
Global
From €2705EUR$2,999USD£2,319GBP
€3607EUR$3,999USD£3,092GBP
- Report
- May 2025
- 112 Pages
Global
From €4284EUR$4,750USD£3,673GBP
- Report
- January 2025
- 173 Pages
Global
From €4505EUR$4,995USD£3,863GBP
- Report
- January 2025
- 210 Pages
Global
From €4505EUR$4,995USD£3,863GBP
- Report
- August 2023
- 85 Pages
United States
From €4059EUR$4,500USD£3,480GBP
- Report
- August 2024
- 98 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- November 2025
- 73 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- July 2025
- 88 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- November 2024
- 101 Pages
Global
From €3500EUR$4,157USD£3,106GBP

The Urinary Tract Infection Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urinary tract infections (UTIs), which are caused by bacteria entering the urinary tract. These drugs are typically antibiotics, such as sulfonamides, cephalosporins, and fluoroquinolones. They are used to kill the bacteria and reduce the symptoms of the infection. Other drugs, such as antifungals, may also be used to treat UTIs.
The Urinary Tract Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. These companies are constantly developing new drugs to treat UTIs, as well as other urological disorders. Show Less Read more